Tofacitinib in rheumatoid arthritis-associated interstitial lung disease: Efficacy and safety analysis from treasure real-life data

Kalyoncu, U.Bilgin, E.Erden, A.Satis, H.Tufan, A.Tekgoz, E.Ates, A.Kucuksahin, O.Yazisiz, V.Kimyon, G.Bes, C.Ertenli, A. I.Kiraz, S.2024-06-132024-06-132021-06-010003-4967https://doi.org/10.1136/annrheumdis-2021-eular.1236https://hdl.handle.net/11452/42156Bu çalışma, 02-05 Haziran 2021 tarihleri arasında düzenlenen Annual European Congress of Rheumatology (EULAR)’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineRheumatologyRheumatologyTofacitinib in rheumatoid arthritis-associated interstitial lung disease: Efficacy and safety analysis from treasure real-life dataMeeting Abstract000692629300123697080Supplement 110.1136/annrheumdis-2021-eular.1236